Cutler Group LP Fsd Pharma Inc. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$0.82 - $1.1 $134 - $180	-164 Closed	0 $0
Q4 2021 Jan 18, 2022	SELL	$0.96 - $1.63 $480 - $815	-500 Reduced 75.3%	164 $0
Q3 2021 Oct 26, 2021	BUY	$1.45 - $1.84 $962 - $1,221	664 New	664 $1,000
Q4 2020 Jan 21, 2021	SELL	$1.36 - $2.7 $680 - $1,350	-500 Closed	0 $0
Q3 2020 Oct 27, 2020	BUY	$2.55 - $4.26 $1,275 - $2,130	500 New	500 $1,000

Ticker HUGE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 38,218,100
Market Cap $146M
Description
FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.